Feasibility Trial of the Circumferential Abdominal Pelvic Pressure Device (CAPP)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Mark Hauswald, University of New Mexico
ClinicalTrials.gov Identifier:
NCT01497756
First received: December 20, 2011
Last updated: August 17, 2012
Last verified: August 2012
  Purpose

A group of midwives and obstetric nurses have been trained to use circumferential abdominal pelvic pressure (CAPP) to treat postpartum hemorrhage. As part of the training follow up any use of a CAPP device will be monitored to identify complications.


Condition Intervention
Postpartum Hemorrhage
Device: CAPP use

Study Type: Interventional
Study Design: Endpoint Classification: Safety Study
Intervention Model: Single Group Assignment
Masking: Open Label
Official Title: Feasibility Trial of the Circumferential Abdominal Pelvic Pressure Device (CAPP)

Resource links provided by NLM:


Further study details as provided by University of New Mexico:

Primary Outcome Measures:
  • Usage [ Time Frame: Eight months ] [ Designated as safety issue: No ]
    Number of patients on whom CAPP is used


Secondary Outcome Measures:
  • Side Effects [ Time Frame: Eight months ] [ Designated as safety issue: Yes ]
    Any recorded complications


Enrollment: 10
Study Start Date: August 2011
Study Completion Date: May 2012
Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: CAPP application
Patients in whom device is used
Device: CAPP use
Any abdominal pelvic pressure

Detailed Description:

Providers will be surveyed twice at 4 and 8 months using open ended methods.

  Eligibility

Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Any patient receiving CAPP during study period.

Exclusion Criteria:

  • None (CAPP is only clinically indicated for obstetric hemorrhage post delivery.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01497756

Locations
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 81435
Sponsors and Collaborators
University of New Mexico
Investigators
Principal Investigator: Mark Hauswald, MD University of New Mexico
  More Information

No publications provided

Responsible Party: Mark Hauswald, Professor, University of New Mexico
ClinicalTrials.gov Identifier: NCT01497756     History of Changes
Other Study ID Numbers: 10-229
Study First Received: December 20, 2011
Results First Received: July 2, 2012
Last Updated: August 17, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Hemorrhage
Postpartum Hemorrhage
Pathologic Processes
Obstetric Labor Complications
Pregnancy Complications
Puerperal Disorders
Uterine Hemorrhage

ClinicalTrials.gov processed this record on August 20, 2014